Not a great experience after AZ bought ZS Pharma - Anonymous employee AstraZeneca Employee Review

2.0
23 Jan 2018
Anonymous employee
Recommend
CEO approval
Business outlook

Pros

Not much on that front. I guess their severance package is half way decent.

Cons

Absolutely no regard for employees of ZS Pharma after they bought the company at the end of 2015. People had many options to leave but a lot were committed to staying and seeing the product for Hyperkalemia launch, despite two CRL's. This loyalty was rewarded by deciding to close the San Mateo site and move the business to Wilmington with no sound rationale. Since the announcement, AZ has had no regard for the employees in San Mateo and have been treating them as disposable assets to be discarded after knowledge is transferred to AZ folks.

Explore other reviews about AstraZeneca

5.0
17 Jun 2026
Recommend
CEO approval
Business outlook

Pros

great place to work and develop!

Cons

could maybe have more transparency

1.0
19 Jun 2026
Recommend
CEO approval
Business outlook

Pros

The page is friendly to make an application.

Cons

As an experienced healthcare analytics and commercial leader, I applied to 104 U.S.-based positions at AstraZeneca between 2025 and 2026 that closely matched my background. Despite receiving interviews from peer organizations, I did not receive a single recruiter interaction. I fully understand the competitiveness of hiring, but such a complete lack of engagement raises questions about potential overreliance on AI screening or unintended bias.

See reviews by: Helpful|Rating|Date|All